510(k) K201908
K201908 is an FDA 510(k) premarket notification submitted by DiaSorin, Inc. for the device "LIAISON Testosterone xt". The FDA issued a decision of Substantially Equivalent on Oct 15, 2020. The device falls under product code CDZ (Radioimmunoassay, Testosterones And Dihydrotestosterone), a Class I device regulated under 21 CFR 862.1680. DiaSorin, Inc. has 73 other 510(k) clearances on record.
Clearance details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- Oct 15, 2020
- Date Received
- Jul 9, 2020
- Clearance Type
- Special
- Expedited Review
- No
- Third Party Review
- No
Device classification
- Device Name
- Radioimmunoassay, Testosterones And Dihydrotestosterone
- Device Class
- Class I
- Regulation Number
- 862.1680
- Review Panel
- CH
- Submission Type
- 510(k)
Need the full FDA record for DiaSorin, Inc.? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.